DiscoverLife Sciences DNA PodcastBiopharma Companies Wrestle with an Outsized Demand for AI Talent
Biopharma Companies Wrestle with an Outsized Demand for AI Talent

Biopharma Companies Wrestle with an Outsized Demand for AI Talent

Update: 2024-11-14
Share

Description

The increasing demand for AI talent in the life sciences industry is presenting a challenge for biopharma HR departments. Companies must compete for skilled workers not only against their competitors but also against tech firms that often offer more attractive compensation packages. Steve Swan, CEO of The Swan Group, sat down with Amar Drawid to discuss the current recruitment landscape for AI talent in the life sciences sector, the challenges companies are encountering, and why the mission of drug developers might give them a competitive advantage over tech companies in appealing to certain candidates.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Biopharma Companies Wrestle with an Outsized Demand for AI Talent

Biopharma Companies Wrestle with an Outsized Demand for AI Talent

Levine Media Group